Search for: "3M Pharmaceuticals" Results 1 - 20 of 86
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 May 2024, 9:01 am by Seeger Weiss
Her work on the 3M litigation included the 11th bellwether trial, which resulted in a $110M verdict for two veterans who suffered from hearing loss and tinnitus caused by defective 3M earplugs. [read post]
28 Feb 2024, 2:00 pm
(Kaye and Freedman, Reference Guide on Statistics, in Reference Manual on Scientific Evidence (3d ed. 2011) 211, 217–218 (Statistics); accord Amador v. 3M Co. [read post]
3 Oct 2023, 9:50 am by Seeger Weiss
Seeger Weiss is pleased to announce a landmark $425 million settlement with AstraZeneca Pharmaceuticals in the Proton-Pump Inhibitor Products Liability Litigation. [read post]
26 Jul 2023, 6:15 am
PFAS are synthetic fluorocarbon compounds whose physical attributes garnered their widespread use, being found in an extensive range of commercial and industrial products, from non-stick cookware and pharmaceuticals to self-care products and fluorinated firefighting foams. [read post]
17 Jul 2023, 12:46 pm by Seeger Weiss
Caleb’s practice focuses on complex litigation involving pharmaceutical injury, medical devices, and dangerous consumer products. [read post]
27 Jun 2023, 5:56 pm by Levin Papantonio
He litigates pharmaceutical, environmental, mass tort and personal injury cases throughout the country. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
In Part One, I reviewed the basic structure and function of the pharmaceutical industry, as well as the theory of harm that the FTC is bringing. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
In Part One, I reviewed the basic structure and function of the pharmaceutical industry, as well as the theory of harm that the FTC is bringing. [read post]
17 May 2023, 9:46 am by Seeger Weiss
Seeley, whose practice focuses on complex litigation involving pharmaceutical injury, medical devices, and dangerous consumer products, has been instrumental in the 3M Combat Arms Earplug multidistrict litigation, contributing to several successful bellwether trial teams representing veterans in their claims against 3M. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
In Neurim Pharmaceuticals (1991) Ltd and another company v Generics UK Ltd and another [2020] EWHC 3270 (Pat), Neurim was successful on all issues. [read post]
11 Jan 2023, 8:29 am by Seeger Weiss
At Seeger Weiss, Seeley’s practice focuses on complex individual and class action litigation involving pharmaceutical injury, medical devices, and dangerous consumer products. [read post]
13 Jan 2022, 6:21 am
The financing markets also supported other types of M&A activity, including XPO Logistics’ $7.8 billion spin-off of GXO Logistics and the $9.3 billion “Reverse Morris Trust” transaction between 3M’s food safety business and Neogen. [read post]
23 Sep 2021, 4:16 pm by Searcy Law
3M Company, the manufacturer of multiple pharmaceutical and consumer products, is the defendant in a large mass tort litigation involving the company’s Bair Hugger warming blankets. [read post]
23 Sep 2021, 4:16 pm by Searcy Law
3M Company, the manufacturer of multiple pharmaceutical and consumer products, is the defendant in a large mass tort litigation involving the company’s Bair Hugger warming blankets. [read post]
23 Sep 2021, 4:16 pm by Searcy Law
3M Company, the manufacturer of multiple pharmaceutical and consumer products, is the defendant in a large mass tort litigation involving the company’s Bair Hugger warming blankets. [read post]
1 May 2021, 9:41 pm by Patent Docs
Colene Blank of 3M Innovative Properties Co., Thomas A. [read post]
1 Mar 2021, 7:49 am by MaxVal
The top assignees from the sector are 3M, Align Technology, Ivoclar Vivadent, Philips, and Warsaw Orthopedic. [read post]
4 Feb 2021, 11:27 am by Florian Mueller
For nothing.Those opposing reform (BASF, Bayer, Nokia, Qualcomm, 3M, Panasonic, the German chemical industry association, the German research-focused pharmaceutical industry association, and Fraunhofer wrote an open letter to politicians ahead of that parliamentary debate, warning against injunction reform (see this German-language press release by the chemical industry). [read post]